1. . Post-injury myelin-breakdown products inhibit axonal growth: an hypothesis to explain the failure of axonal regeneration in the mammalian central nervous system. Bibl Anat 1982; 23: 1–11.
2. , . Antibody against myelin-associated inhibitor of neurite growth neutralizes nonpermissive substrate properties of CNS white matter. Neuron 1988; 1: 85–96.
, , , et al. Myelin-associated glycoprotein interacts with the Nogo66 receptor to inhibit neurite outgrowth
. Neuron 2002
4. , , , et al. Myelin-associated glycoprotein as a functional ligand for the Nogo-66 receptor. Science 2002; 297: 1190–3.
5. , , , et al. LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex. Nat Neurosci 2004; 7: 221–8.
6. , , , et al. p75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp. Nature 2002; 420: 74–8.
7. , , , et al. A p75(NTR) and Nogo receptor complex mediates repulsive signaling by myelin-associated glycoprotein. Nat Neurosci 2002; 5: 1302–8.
8. , , , et al. PirB is a functional receptor for myelin inhibitors of axonal regeneration. Science 2008; 322: 967–70.
9. , , , et al. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature 2000; 403: 434–9.
10. , , , et al. Identification of the Nogo inhibitor of axon regeneration as a reticulon protein. Nature 2000; 403: 439–44.
11. , , , et al. Identification of myelin-associated glycoprotein as a major myelin-derived inhibitor of neurite growth. Neuron 1994; 13: 805–11.
12. , , , et al. A novel role for myelin-associated glycoprotein as an inhibitor of axonal regeneration. Neuron 1994; 13: 757–67.
13. , , , et al. Inhibitor of neurite outgrowth in humans. Nature 2000; 403: 383–4.
14. , , . Cell body response to injury in motoneurons and primary sensory neurons of a mutant mouse, Ola (Wld), in which Wallerian degeneration is delayed. J Comp Neurol 1995; 359: 653–62.
15. , , , et al. Delayed response to denervation in muscles of C57BL/Ola mice. Neuroscience 1991; 43: 279–83.
16. , , . Consequences of slow Wallerian degeneration for regenerating motor and sensory axons. J Neurobiol 1992; 23: 521–36.
17. , , . Very slow retrograde and Wallerian degeneration in the CNS of C57BL/Ola mice. Eur J Neurosci 1991; 3: 102–5.
18. , . Two membrane protein fractions from rat central myelin with inhibitory properties for neurite growth and fibroblast spreading. J Cell Biol 1988; 106: 1281–8.
19. , , , et al. Recovery from spinal cord injury mediated by antibodies to neurite growth inhibitors. Nature 1995; 378: 498–501.
20. , . Axonal regeneration in the rat spinal cord produced by an antibody against myelin-associated neurite growth inhibitors. Nature 1990; 343: 269–72.
21. , , , et al. Identification and characterization of a bovine neurite growth inhibitor (bNI-220). J Biol Chem 1998; 273: 19283–93.
22. , , , et al. NOGO mRNA expression in adult and fetal human and rat nervous tissue and in weight drop injury. Exp Neurol 2001; 169: 319–28.
23. , , , et al. Patterns of Nogo mRNA and protein expression in the developing and adult rat and after CNS lesions. J Neurosci 2002; 22: 3553–67.
24. , , , et al. Localization of Nogo-A and Nogo-66 receptor proteins at sites of axon-myelin and synaptic contact. J Neurosci 2002; 22: 5505–15.
25. , , , et al. NSP-encoded reticulons, neuroendocrine proteins of a novel gene family associated with membranes of the endoplasmic reticulum. J Cell Sci 1994; 107: 2403–16.
26. , , , et al. Membrane Topologies and Receptors of the Oligodendrocyte Protein Nogo–A. Program 333.10, Washington, DC: Society for Neuroscience, 2002.
27. , , . Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration. Nature 2001; 409: 341–6.
28. , , , et al. Mapping the Functional Inhibitory Sites of Nogo – A. Discovery of Regulated Expression following Neuronal Injury. Program 333.12. Washington, DC: Society for Neuroscience, 2002.
29. , , . Temporal changes in PO and MBP gene expression after crush-injury of the adult peripheral nerve. Brain Res 1988; 464: 133–41.
30. , , , et al. Nogo-A expressed in Schwann cells impairs axonal regeneration after peripheral nerve injury. J Cell Biol 2002; 159: 29–35.
31. , , , et al. Axon regeneration in young adult mice lacking Nogo-A/B. Neuron 2003; 38: 187–99.
32. , , , et al. Lack of enhanced spinal regeneration in Nogo-deficient mice. Neuron 2003; 38: 213–24.
33. , , , et al. Systemic deletion of the myelin-associated outgrowth inhibitor Nogo-A improves regenerative and plastic responses after spinal cord injury. Neuron 2003; 38: 201–11.
34. , , , et al. Siglecs: a family of sialic-acid binding lectins. Glycobiology 1998; 8: v.
35. , , , et al. Two forms of 1B236/myelin-associated glycoprotein, a cell adhesion molecule for postnatal neural development, are produced by alternative splicing. Proc Natl Acad Sci U S A 1987; 84: 4337–41.
36. , , . The amino acid sequences of the myelin-associated glycoproteins: homology to the immunoglobulin gene superfamily. J Cell Biol 1987; 104: 957–65.
37. , , , et al. Structure and function of the myelin-associated glycoproteins. Ann N Y Acad Sci 1990; 605: 302–12.
38. . Myelin-associated glycoprotein. Location and potential functions. Ann N Y Acad Sci 1990; 605: 29–43.
39. , , , et al. The myelin-associated glycoprotein is enriched in multivesicular bodies and periaxonal membranes of actively myelinating oligodendrocytes. J Cell Biol 1989; 109: 2417–26.
40. . Myelin-associated glycoprotein: a role in myelination and in the inhibition of axonal regeneration? Curr Opin Neurobiol 1995; 5: 588–95.
41. . Myelin-associated glycoprotein in development and disease. Dev Neurosci 1983; 6: 285–303.
42. , , , et al. Myelination in the absence of myelin-associated glycoprotein. Nature 1994; 369: 747–50.
43. , , , et al. Mice deficient for the myelin-associated glycoprotein show subtle abnormalities in myelin. Neuron 1994; 13: 229–46.
44. , , , et al. Crucial role for the myelin-associated glycoprotein in the maintenance of axon-myelin integrity. Eur J Neurosci 1995; 7: 511–15.
45. , , , et al. Soluble myelin-associated glycoprotein released from damaged white matter inhibits axonal regeneration. Mol Cell Neurosci 2001; 18: 259–69.
46. , , , et al. Soluble myelin-associated glycoprotein (MAG) found in vivo inhibits axonal regeneration. Mol Cell Neurosci 1997; 9: 333–46.
47. , , , et al. Myelin-associated glycoprotein inhibits neurite/axon growth and causes growth cone collapse. J Neurosci Res 1996; 46: 404–14.
48. , , , et al. Myelin-associated glycoprotein in myelin and expressed by Schwann cells inhibits axonal regeneration and branching. Mol Cell Neurosci 1998; 12: 79–91.
49. , , , et al. Lack of evidence that myelin-associated glycoprotein is a major inhibitor of axonal regeneration in the CNS. Neuron 1995; 15: 1375–81.
50. . The muddle with MAG. Mol Cell Neurosci 1996; 8: 84–92.
51. , , , et al. Disruption of the gene for the myelin-associated glycoprotein improves axonal regrowth along myelin in C57BL/Wlds mice. Neuron 1996; 16: 1107–13.
52. , , , et al. Oligodendrocyte-myelin glycoprotein (OMgp) is an inhibitor of neurite outgrowth. J Neurochem 2002; 82: 1566–9.
53. , , , et al. Expression of the oligodendrocyte-myelin glycoprotein by neurons in the mouse central nervous system. J Neurochem 1998; 70: 1704–11.
54. , . Oligodendrocyte myelin glycoprotein (OMgp): evolution, structure and function. Brain Res Brain Res Rev 2004; 45: 115–24.
55. , , , et al. The oligodendrocyte-myelin glycoprotein gene is highly expressed during the late stages of myelination in the rat central nervous system. Brain Res Dev Brain Res 2003; 144: 159–68.
56. , . A phosphatidylinositol-linked peanut agglutinin-binding glycoprotein in central nervous system myelin and on oligodendrocytes. J Cell Biol 1988; 106: 1273–9.
57. , , , et al. Oligodendrocyte myelin glycoprotein growth inhibition function requires its conserved leucine-rich repeat domain, not its glycosylphosphatidyl-inositol anchor. J Neurochem 2003; 85: 889–97.
58. , , , et al. Truncated soluble Nogo receptor binds Nogo-66 and blocks inhibition of axon growth by myelin. J Neurosci 2002; 22: 8876–83.
59. , , , et al. Nogo receptor mRNA expression in intact and regenerating CNS neurons. Mol Cell Neurosci 2002; 20: 537.
60. , , . The Nogo receptor, its ligands and axonal regeneration in the spinal cord; a review. J Neurocytol 2002; 31: 93–120.
61. , , , et al. Structure and axon outgrowth inhibitor binding of the Nogo-66 receptor and related proteins. EMBO J 2003; 22: 3291–302.
62. , , , et al. Structure of the Nogo receptor ectodomain: a recognition module implicated in myelin inhibition. Neuron 2003; 38: 177–85.
63. , , , et al. Myelin-associated glycoprotein interacts with ganglioside GT1b. A mechanism for neurite outgrowth inhibition. J Biol Chem 2001; 276: 20280–5.
64. , , , et al. Gangliosides are functional nerve cell ligands for myelin-associated glycoprotein (MAG), an inhibitor of nerve regeneration. Proc Natl Acad Sci U S A 2002; 99: 8412–17.
65. , , , et al. Myelin-associated glycoprotein interacts with neurons via a sialic acid binding site at ARG118 and a distinct neurite inhibition site. J Cell Biol 1997; 138: 1355–66.
66. , , , et al. Characterization of two novel proteins, NgRH1 and NgRH2, structurally and biochemically homologous to the Nogo-66 receptor. J Neurochem 2003; 85: 717–28.
67. , , , et al. The Nogo-66 receptor homolog NgR2 is a sialic acid-dependent receptor selective for myelin-associated glycoprotein. J Neurosci 2005; 25: 808–22.
68. , , , et al. Characterization of a distinctive motif of the low molecular weight neurotrophin receptor that modulates NGF-mediated neurite growth. Eur J Neurosci 1996; 8: 870–9.
69. , , , et al. Prior exposure to neurotrophins blocks inhibition of axonal regeneration by MAG and myelin via a cAMP-dependent mechanism. Neuron 1999; 22: 89–101.
70. , . From cell death to neuronal regeneration, effects of the p75 neurotrophin receptor depend on interactions with partner subunits. Sci STKE 2004; 2004: pe24.
71. . p75NTR is positively promiscuous: novel partners and new insights. Neuron 2004; 42: 529–33.
72. , . TNF receptor distribution in human tissues. Int Rev Exp Pathol 1993; 34: 149–56.
73. , , , et al. Neurotrophins and their receptors in nerve injury and repair. Neurochem Int 1997; 30: 347–74.
74. , , , et al. A TNF receptor family member, TROY, is a coreceptor with Nogo receptor in mediating the inhibitory activity of myelin inhibitors. Neuron 2005; 45: 345–51.
75. , , , et al. TAJ/TROY, an orphan TNF receptor family member, binds Nogo-66 receptor 1 and regulates axonal regeneration. Neuron 2005; 45: 353–9.
76. , , , et al. Paired immunoglobulin-like receptor B knockout does not enhance axonal regeneration or locomotor recovery after spinal cord injury. J Biol Chem 2011; 286: 1876–83.
77. , , , et al. Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury. Neuron 2004; 44: 439–51.
78. , , , et al. Experience-driven plasticity of visual cortex limited by myelin and Nogo receptor. Science 2005; 309: 2222–6.
79. , , , et al. PirB restricts ocular-dominance plasticity in visual cortex. Science 2006; 313: 1795–800.
80. , , , et al. Reactivation of ocular dominance plasticity in the adult visual cortex. Science 2002; 298: 1248–51.
81. , , , et al. Inactivation of Rho signaling pathway promotes CNS axon regeneration. J Neurosci 1999; 19: 7537–47.
82. , , , et al. Rho signaling pathway targeted to promote spinal cord repair. J Neurosci 2002; 22: 6570–7.
83. , , , et al. Characterization of new cell permeable C3-like proteins that inactivate Rho and stimulate neurite outgrowth on inhibitory substrates. J Biol Chem 2002; 277: 32820–9.
84. , , . The p75 receptor transduces the signal from myelin-associated glycoprotein to Rho. J Cell Biol 2002; 157: 565–70.
85. , , , et al. PKC mediates inhibitory effects of myelin and chondroitin sulfate proteoglycans on axonal regeneration. Nat Neurosci 2004; 7: 261–8.
86. , . The p75 receptor acts as a displacement factor that releases Rho from Rho-GDI. Nat Neurosci 2003; 6: 461–7.
87. , . The neurotrophin receptor p75(NTR): novel functions and implications for diseases of the nervous system. Nat Neurosci 2002; 5: 1131–6.
88. , , , et al. Regulation of cell survival by secreted proneurotrophins. Science 2001; 294: 1945–8.
89. , . , et al. Neurotrophin p75 receptor is involved in neuronal damage by prion peptide-(106–126). J Biol Chem 2001; 276: 38929–33.
90. , , , et al. Role of p75 neurotrophin receptor in the neurotoxicity by beta-amyloid peptides and synergistic effect of inflammatory cytokines. J Exp Med 2002; 195: 907–18.
91. , , , et al. An evolutionarily conserved transmembrane protein that is a novel downstream target of neurotrophin and ephrin receptors. J Neurosci 2001; 21: 176–85.
92. , , , et al. Neurotrophin receptors: mediators of life and death. Brain Res Brain Res Rev 1998; 26: 295–301.
93. , , , et al. Sortilin is essential for proNGF-induced neuronal cell death. Nature 2004; 427: 843–8.
94. , , , et al. The zinc finger protein NRIF interacts with the neurotrophin receptor p75(NTR) and participates in programmed cell death. EMBO J 1999; 18: 6050–61.
95. , , , et al. NRAGE, a novel MAGE protein, interacts with the p75 neurotrophin receptor and facilitates nerve growth factor-dependent apoptosis. Neuron 2000; 27: 279–88.
96. , , , et al. Functional interaction of Fas-associated phosphatase-1 (FAP-1) with p75(NTR) and their effect on NF-kappaB activation. FEBS Lett 1999; 460: 191–8.
97. , , , et al. NADE, a p75NTR-associated cell death executor, is involved in signal transduction mediated by the common neurotrophin receptor p75NTR. J Biol Chem 2000; 275: 17566–70.
98. , , , et al. TRAF family proteins interact with the common neurotrophin receptor and modulate apoptosis induction. J Biol Chem 1999; 274: 30202–8.
99. , , . Association of p75(NTR) with caveolin and localization of neurotrophin-induced sphingomyelin hydrolysis to caveolae. J Biol Chem 1997; 272: 10922–7.
100. , , . Identification of interleukin 1 receptor-associated kinase as a conserved component in the p75-neurotrophin receptor activation of nuclear factor-kappa B. J Biol Chem 2002; 277: 28010–18.
101. , , . Association of a purine-analogue-sensitive protein kinase activity with p75 nerve growth factor receptors. Mol Biol Cell 1993; 4: 71–8.
102. , , , et al. Phosphorylation of the common neurotrophin receptor p75 by p38beta2 kinase affects NF-kappaB and AP-1 activities. J Mol Neurosci 2000; 15: 19–29.
103. , , , et al. The p75NTR-interacting protein SC1 inhibits cell cycle progression by transcriptional repression of cyclin E. J Cell Biol 2004; 164: 985–96.
104. , , . A rapid switch in sympathetic neurotransmitter release properties mediated by the p75 receptor. Nat Neurosci 2002; 5: 539–45.
105. , , , et al. Chemical transmission between rat sympathetic neurons and cardiac myocytes developing in microcultures: evidence for cholinergic, adrenergic, and dual-function neurons. Proc Natl Acad Sci U S A 1976; 73: 4225–9.
106. , , . Nerve growth factor modulates synaptic transmission between sympathetic neurons and cardiac myocytes. J Neurosci 1997; 17: 9573–82.
107. , , , et al. Rho signaling pathway targeted to promote spinal cord repair. J Neurosci 2002; 22: 6570–7.
108. , , . Rho kinase inhibition enhances axonal regeneration in the injured CNS. J Neurosci 2003; 23: 1416–23.
109. , , , et al. Nogo-A and myelin-associated glycoprotein mediate neurite growth inhibition by antagonistic regulation of RhoA and Rac1. J Neurosci 2002; 22: 10368–76.
110. , , ., et al. Phosphorylation of cofilin by LIM-kinase is necessary for semaphorin 3A-induced growth cone collapse. Nat Neurosci 2001; 4: 367–73.
111. , , . Myelin-associated inhibitors regulate cofilin phosphorylation and neuronal inhibition through LIM kinase and Slingshot phosphatase. J Neurosci 2006; 26: 1006–15.
112. , , , et al. Myelin-associated glycoprotein inhibits microtubule assembly by a Rho-kinase-dependent mechanism. J Biol Chem 2006; 281: 15970–9.
113. , , , et al. Identification of CRMP4 as a convergent regulator of axon outgrowth inhibition. J Neurosci 2007; 27: 1702–11.
114. , , , et al. A novel role for PTEN in the inhibition of neurite outgrowth by myelin-associated glycoprotein in cortical neurons. Mol Cell Neurosci 2011; 46: 235–44.
115. , , , et al. A therapeutic vaccine approach to stimulate axon regeneration in the adult mammalian spinal cord. Neuron 1999; 24: 639–47.
116. , , . Nogo-66 receptor antagonist peptide promotes axonal regeneration. Nature 2002; 417: 547–51.
117. , , , et al. A molecular switch for the consolidation of long-term memory: cAMP-inducible gene expression. Ann N Y Acad Sci 1995; 758: 261–86.
118. , , . Effects of cAMP simulate a late stage of LTP in hippocampal CA1 neurons. Science 1993; 260: 1661–4.
119. , , , et al. Calcium-stimulated adenylyl cyclase activity is critical for hippocampus-dependent long-term memory and late phase LTP. Neuron 1999; 23: 787–98.
120. , , , et al. Altered behavior and long-term potentiation in type I adenylyl cyclase mutant mice. Proc Natl Acad Sci U S A 1995; 92: 220–4.
121. , . Presynaptic facilitation revisited: state and time dependence. J Neurosci 1996; 16: 425–35.
122. , , , et al. Intracellular injection of the catalytic subunit of cyclic AMP-dependent protein kinase simulates facilitation of transmitter release underlying behavioral sensitization in Aplysia. Proc Natl Acad Sci U S A 1980; 77: 7492–6.
123. , , , et al. Inhibitor of adenosine 3’:5’-monophosphate-dependent protein kinase blocks presynaptic facilitation in Aplysia. J Neurosci 1982; 2: 1673–81.
124. , , . Cognitive neuroscience and the study of memory. Neuron 1998; 20: 445–68.
125. , , , et al. Conversion of neuronal growth cone responses from repulsion to attraction by cyclic nucleotides. Science 1998; 281: 1515–18.
126. , , . cAMP-induced switching in turning direction of nerve growth cones. Nature 1997; 388: 275–9.
127. , , , et al. Neuronal cyclic AMP controls the developmental loss in ability of axons to regenerate. 2001; J Neurosci 21: 4731–9.
128. , , , et al. The astrocyte/meningeal cell interface is a barrier to neurite outgrowth which can be overcome by manipulation of inhibitory molecules or axonal signalling pathways. Mol Cell Neurosci 2003; 24: 913–25.
129. , , , et al. Intraocular injection of dibutyryl cyclic AMP promotes axon regeneration in rat optic nerve. Exp Neurol 2004; 186: 124–33.
130. , , , et al. Intravitreal injections of neurotrophic factors and forskolin enhance survival and axonal regeneration of axotomized beta ganglion cells in cat retina. Neuroscience 2003; 116: 733–42.
131. , . Peripheral injury enhances central regeneration of primary sensory neurones. Nature 1984; 309: 791–3.
132. , . The induction of a regenerative propensity in sensory neurons following peripheral axonal injury. J Neurocytol 1986; 15: 585–94.
133. , . Regeneration of dorsal column fibers into and beyond the lesion site following adult spinal cord injury” Neuron 1999; 23: 83–91.
134. , , , et al. Regeneration of sensory axons within the injured spinal cord induced by intraganglionic cAMP elevation. Neuron 2002; 34: 885–93.
135. , , , et al. Spinal axon regeneration induced by elevation of cyclic AMP. Neuron 2002; 34: 895–903.
136. , , , et al. Combinatorial therapy with neurotrophins and cAMP promotes axonal regeneration beyond sites of spinal cord injury. J Neurosci 2004; 24: 6402–9.
137. , , , et al. The phosphodiesterase inhibitor rolipram delivered after a spinal cord lesion promotes axonal regeneration and functional recovery. Proc Natl Acad Sci U S A 2004; 101: 8786–90.
138. , , , et al. cAMP and Schwann cells promote axonal growth and functional recovery after spinal cord injury. Nat Med 2004; 10: 610–16.
139. , , , et al. Neurotrophins elevate cAMP to reach a threshold required to overcome inhibition by MAG through extracellular signal-regulated kinase-dependent inhibition of phosphodiesterase. J Neurosci 2003; 23: 11770–7.
140. , , , et al. Arginase I and polyamines act downstream from cyclic AMP in overcoming inhibition of axonal growth MAG and myelin in vitro. Neuron 2002; 35: 711–19.
141. , , , et al. Arginase I: a limiting factor for nitric oxide and polyamine synthesis by activated macrophages? Am J Physiol Regul Integr Comp Physiol 2000; 279: R2237–42.
142. , , , et al. Regulatory role of arginase I and II in nitric oxide, polyamine, and proline syntheses in endothelial cells. Am J Physiology Endocrinol Metab 2001; 280: E75–82.
143. , , , et al. Increased synthesis of spermidine as a result of upregulation of arginase I promotes axonal regeneration in culture and in vivo. J Neurosci 2009; 29: 9545–52.
144. , , . Axonal growth therapeutics: regeneration or sprouting or plasticity? Trends Neurosci 2008; 31: 215–20.
145. . Neurotrophin-regulated signalling pathways. Philos Trans R Soc Lond B Biol Sci 2006; 361: 1545–64.
146. , , , et al. Involvement of ras p21 in neurotrophin-induced response of sensory, but not sympathetic neurons. J Cell Biol 1993; 121: 665–72.
147. , . Phosphoinositide 3-kinase signalling events controlling axonal morphogenesis. Biochem Soc Trans 2007; 35: 207–10.
148. , , . Neurotrophic factors and axonal growth. Curr Opin Neurobiol 2002; 12: 523–31.
149. , , . Raf and akt mediate distinct aspects of sensory axon growth. Neuron 2002; 35: 65–76.
150. , , , et al. Neurotrophins support regenerative axon assembly over CSPGs by an ECM-integrin-independent mechanism. J Cell Sci 2006; 119: 2787–96.
151. , , , et al. Promoting axon regeneration in the adult CNS by modulation of the PTEN/mTOR pathway. Science 2008; 322: 963–66.
152. , , , et al. Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance. Proc Natl Acad Sci U S A 2007; 104: 16158–63.
153. , . Defining the role of mTOR in cancer. Cancer Cell 2007; 12: 9–22.
154. , , , et al. Phospholipase C-gamma and phosphoinositide 3-kinase mediate cytoplasmic signaling in nerve growth cone guidance. Neuron 1999; 23: 139–48.
155. , , , et al. Netrin-1-mediated axon outgrowth requires deleted in colorectal cancer-dependent MAPK activation. Nature 2002; 417: 443–7.
156. , , , et al. Adaptation in the chemotactic guidance of nerve growth cones. Nature 2002; 417: 411–18.
157. , . The netrin-1 receptor DCC promotes filopodia formation and cell spreading by activating Cdc42 and Rac1. Mol Cell Neurosci 2002; 19: 1–17.
158. , , , et al. Neurotrophins and netrins require calcineurin/NFAT signaling to stimulate outgrowth of embryonic axons. Cell 2003; 113: 657–70.
159. , , , et al. Netrin stimulates tyrosine phosphorylation of the UNC-5 family of netrin receptors and induces Shp2 binding to the RCM cytodomain. J Biol Chem 2001; 276: 40917–25.
160. , , , et al. cAMP-dependent growth cone guidance by netrin-1. Neuron 1997; 19: 1225–35.
161. , , , et al. Calcium signalling in the guidance of nerve growth by netrin-1. Nature 2000; 403: 93–8.
162. , , , et al. Cyclic AMP/GMP-dependent modulation of Ca2+ channels sets the polarity of nerve growth-cone turning. Nature 2003; 424: 990–5.
163. , . Emerging roles for semaphorins in neural regeneration. Brain Res Brain Res Rev 2001; 35: 36–54.
164. , , . Peripheral nerve injury fails to induce growth of lesioned ascending dorsal column axons into spinal cord scar tissue expressing the axon repellent Semaphorin3A. Eur J Neurosci 2001; 13: 457–71.
165. , , , et al. Expression of the gene encoding the chemorepellent semaphorin III is induced in the fibroblast component of neural scar tissue formed following injuries of adult but not neonatal CNS. Mol Cell Neurosci 1999; 13: 143–66.
166. , , . Regulation of semaphorin III/collapsin-1 gene expression during peripheral nerve regeneration. Exp Neurol 1998; 153: 313–27.
167. , , , et al. Evidence for a role of the chemorepellent semaphorin III and its receptor neuropilin-1 in the regeneration of primary olfactory axons. J Neurosci 1998; 18: 9962–76.
168. , , , et al. Slit proteins bind Robo receptors and have an evolutionarily conserved role in repulsive axon guidance. Cell 1999; 96: 795–806.
169. , , . Slit is the midline repellent for the robo receptor in Drosophila. Cell 1999; 96: 785–94.
170. , , , et al. Vertebrate slit, a secreted ligand for the transmembrane protein roundabout, is a repellent for olfactory bulb axons. Cell 1999; 96: 807–18.
171. , , , et al. Signal transduction in neuronal migration: roles of GTPase activating proteins and the small GTPase Cdc42 in the Slit-Robo pathway. Cell 2001; 107: 209–21.
172. , , , et al. Spatiotemporal expression patterns of slit and robo genes in the rat brain. J Comp Neurol 2002; 442: 130–55.
173. , , , et al. Slit and glypican-1 mRNAs are coexpressed in the reactive astrocytes of the injured adult brain. Glia 2003; 42: 130–8.
174. , . Ephrin-As as receptors in topographic projections. Trends Neurosci 2002; 25: 145–9.
175. , , , et al. Ephrin-A5 induces collapse of growth cones by activating Rho and Rho kinase. J Cell Biol 2000; 149: 263–70.
176. , , , et al. Ephrin-B2 and EphB2 regulation of astrocyte-meningeal fibroblast interactions in response to spinal cord lesions in adult rats. J Neurosci 2003; 23: 7789–800.
177. , , . Ephrin-A binding and EphA receptor expression delineate the matrix compartment of the striatum. J Neurosci 1999; 19: 4962–71.
178. , , , et al. Induction of Eph B3 after spinal cord injury. Exp Neurol 1999; 156: 218–22.
179. , , , et al. Upregulation of EphA receptor expression in the injured adult rat spinal cord. Cell Transplant 2002; 11: 229–39.
180. , , , et al. Cloning of AL-1, a ligand for an Eph-related tyrosine kinase receptor involved in axon bundle formation. Neuron 1995; 14: 973–81.
181. , , , et al. Graded expression patterns of ephrin-As in the superior colliculus after lesion of the adult mouse optic nerve. Mech Dev 2001; 106: 119–27.
182. , . Functional consequences of coincident expression of EphA receptors and ephrin-A ligands. Neuron 1999; 22: 636–9.
183. , , , et al. Astroglial reaction in the gray matter lumbar segments after midthoracic transection of the adult rat spinal cord. Exp Neurol 1981; 73: 365–77.
184. , , , et al. Proteins of the intermediate filament cytoskeleton as markers for astrocytes and human astrocytomas. Mol Chem Neuropathol 1994; 21: 155–76.
185. , , . The proteoglycan chondroitin sulfate is present in a subpopulation of cultured astrocytes and in their precursors. Dev Biol 1987; 123: 282–5.
186. , , . The chondroitin sulfate proteoglycans neurocan, brevican, phosphacan, and versican are differentially regulated following spinal cord injury. Exp Neurol 2003; 182: 399–411.
187. , , . The chondroitin sulfate proteoglycans neurocan and phosphacan are expressed by reactive astrocytes in the chronic CNS glial scar. J Neurosci 1999; 19: 10778–88.
188. , , . Changes in distribution, cell associations, and protein expression levels of NG2, neurocan, phosphacan, brevican, versican V2, and tenascin-C during acute to chronic maturation of spinal cord scar tissue. J Neurosci Res 2003; 71: 427–44.
189. , , , et al. Reduction of neurite outgrowth in a model of glial scarring following CNS injury is correlated with the expression of inhibitory molecules on reactive astrocytes. J Neurosci 1991; 11: 3398–411.
190. , , , et al. Bovine CNS myelin contains neurite growth-inhibitory activity associated with chondroitin sulfate proteoglycans. J Neurosci 1999; 19: 8979–89.
191. , , , et al. An inhibitor of neurite outgrowth produced by astrocytes. J Cell Sci 1994; 107: 1687–95.
192. , , , et al. Robust regeneration of adult sensory axons in degenerating white matter of the adult rat spinal cord. J Neurosci 1999; 19: 5810–22.
193. , , , et al. Functional regeneration of respiratory pathways after spinal cord injury. Nature 2011; 475: 196–200.
194. , , , et al. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 2002; 416: 636–40.
195. , , , et al. Suppression of Rho-kinase activity promotes axonal growth on inhibitory CNS substrates. Mol Cell Neurosci 2003; 22: 405–16.
196. , , , et al. The Rho/ROCK pathway mediates neurite growth-inhibitory activity associated with the chondroitin sulfate proteoglycans of the CNS glial scar. Mol Cell Neurosci 2003; 22: 319–30.